Loss-of-function mutations in FREM2 disrupt eye morphogenesis

被引:13
|
作者
Zhang, Xiayin [1 ]
Wang, Dongni [1 ]
Dongye, Meimei [1 ]
Zhu, Yi [1 ,2 ]
Chen, Chuan [1 ,2 ]
Wang, Ruixin [1 ]
Long, Erping [1 ]
Liu, Zhenzhen [1 ]
Wu, Xiaohang [1 ]
Lin, Duoru [1 ]
Chen, Jingjing [1 ]
Lin, Zhuoling [1 ]
Wang, Jinghui [1 ]
Li, Wangting [1 ]
Li, Yang [3 ]
Li, Dongmei [3 ]
Lin, Haotian [1 ]
机构
[1] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China
[2] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA
[3] Capital Med Univ, Beijing Key Lab Ophthalmol & Visual Sci, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing 100730, Peoples R China
基金
中国国家自然科学基金;
关键词
Isolated cryptophthalmos; FREM2; mutation; Development of eyelids; Ocular abnormalities; Genotype-phenotype correlation; FRASER-SYNDROME; PRENATAL-DIAGNOSIS; MOUSE; MICROPHTHALMIA; ANOPHTHALMIA; EXPRESSION; GENERATION; GENETICS; PAX6;
D O I
10.1016/j.exer.2019.02.013
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Cryptophthalmos is a rare congenital disorder characterized by ocular dysplasia with eyelid malformation. Complete cryptophthalmos is characterized by the presence of continuous skin from the forehead over the eyes and onto the cheek, along with complete fusion of the eyelids. In the present study, we characterized the clinical manifestations of three patients with isolated bilateral cryptophthalmos. These patients shared the same c.6499C > T missense mutation in the FRAS1-related extracellular matrix protein 2 (FREM2) gene, while each individual presented an additional nonsense mutation in the same gene (Patient #1, c.2206C > T; Patient #2, c.5309G > A; and Patient #3, c.4063C > T). Then, we used CRISPR/Cas9 to generate mice carrying Frem2(R725X/R2156W) compound heterozygous mutations, and showed that these mice recapitulated the human isolated cryptophthalmos phenotype. We detected FREM2 expression in the outer plexiform layer of the retina for the first time in the cryptophthalmic eyes, and the levels were comparable to the wild-type mice. Moreover, a set of different expressed genes that may contribute secondarily to the phenotypes were identified by performing RNA sequencing (RNA-seq) of the fetal Frem2 mutant mice. Our findings extend the spectrum of FREM2 mutations, and provide insights into opportunities for the prenatal diagnosis of isolated cryptophthalmos. Furthermore, our work highlights the importance of the FREM2 protein during the development of eyelids and the anterior segment of the eyeballs, establishes a suitable animal model for studying epithelial reopening during eyelid development and serves as a valuable reference for further mechanistic studies of the pathogenesis of isolated cryptophthalmos.
引用
收藏
页码:302 / 312
页数:11
相关论文
共 50 条
  • [21] Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis
    Wu, David
    Yu, Wenhao
    Kishikawa, Hiroko
    Folkerth, Rebecca D.
    Iafrate, A. John
    Shen, Yiping
    Xin, Winme
    Sims, Katherine
    Hu, Guo-Fu
    ANNALS OF NEUROLOGY, 2007, 62 (06) : 609 - 617
  • [22] MNGIE is caused by thymidine phosphorylase loss-of-function mutations
    Nishino, I
    Spinazzola, A
    DiMauro, S
    Carlo, JR
    Hahn, AF
    Steiner, I
    Butler, I
    Bender, AM
    Salberg, LM
    Hammans, S
    Hirano, M
    NEUROLOGY, 1999, 52 (06) : A258 - A258
  • [23] The role of MGA loss-of-function mutations in lung adenocarcinomas
    Zhang, Xiaoyang
    Francis, Joshua
    Lin, Charles
    Rahl, Peter
    Bradner, James
    Young, Richard
    MOLECULAR CANCER RESEARCH, 2015, 13
  • [24] Filaggrin loss-of-function mutations and association with allergic diseases
    Rodriguez, Elke
    Illig, Thomas
    Weidinger, Stephan
    PHARMACOGENOMICS, 2008, 9 (04) : 399 - 413
  • [25] The role of filaggrin loss-of-function mutations in atopic dermatitis
    O'Regan, Grainne M.
    Irvine, Alan D.
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 8 (05) : 406 - 410
  • [26] Loss-of-function mutations in filaggrin gene and malignant melanoma
    Kezic, S.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (02) : 193 - 193
  • [27] Hematopoietic malignancies demonstrate loss-of-function mutations of BAX
    Meijerink, JPP
    Mensink, EJBM
    Wang, K
    Sedlak, TW
    Slöetjes, AW
    de Witte, T
    Waksman, G
    Korsmeyer, SJ
    BLOOD, 1998, 91 (08) : 2991 - 2997
  • [28] Loss-of-function EA2 mutations are associated with impaired neuromuscular transmission
    Jen, J
    Wan, J
    Graves, M
    Yu, H
    Mock, AF
    Coulin, CJ
    Kim, G
    Yue, Q
    Papazian, DM
    Baloh, RW
    NEUROLOGY, 2001, 57 (10) : 1843 - 1848
  • [29] NOVEL IMMUNODYSREGULATION DISORDER CAUSED BY LOSS-OF-FUNCTION MUTATIONS IN SBNO2
    Jing, Huie
    Dove, Christopher
    Zhang, Yu
    Price, Susan
    Koneti, Rao
    Su, Helen C.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (03) : 275 - 275
  • [30] Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma
    Gartside, Michael G.
    Chen, Huaibin
    Ibrahimi, Omar A.
    Byron, Sara A.
    Curtis, Amy V.
    Wellens, Candice L.
    Bengston, Ana
    Yudt, Laura M.
    Eliseenkova, Anna V.
    Ma, Jinghong
    Curtin, John A.
    Hyder, Pilar
    Harper, Ursula L.
    Riedesel, Erica
    Mann, Graham J.
    Trent, Jeffrey M.
    Bastian, Boris C.
    Meltzer, Paul S.
    Mohammadi, Moosa
    Pollock, Pamela M.
    MOLECULAR CANCER RESEARCH, 2009, 7 (01) : 41 - 54